J&J’s single-dose COVID-19 vaccine offers 100% protection against hospitalisation
Johnson & Johnson announced today that the single-dose COVID-19 vaccine candidate developed by Janssen Pharmaceuticals showed 66% efficacy overall in
Read moreJohnson & Johnson announced today that the single-dose COVID-19 vaccine candidate developed by Janssen Pharmaceuticals showed 66% efficacy overall in
Read moreDutch data logger manufacturer, SenseAnywhere, offers a simple solution to overcome the COVID-19 vaccine supply chain challenge. The company has
Read moreBioNTech and InstaDeep have entered into an agreement to establish a joint AI Innovation Lab in London, United Kingdom and
Read moreModerna announced its vaccine candidate against COVID-19 named mRNA-1273, has met Phase 3 study statistical criteria with a vaccine efficacy
Read moreGovernments around the world are scrambling to prepare for the rollout of the Pfizer and BioNTech COVID-19 vaccine, with many
Read moreUK clinicians are being advised to “think carefully” before ordering tests as pharma group Roche is experiencing logistical challenges due
Read moreBritish pharmaceutical company AstraZeneca has reached a landmark $750 million agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and the
Read moreThe U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for emergency use of Gilead’s remdesivir
Read moreWhile COVID-19 transmission is expanding, the Japanese government has agreed to raise its Avigan® Tablet (favipiravir) stockpile, which is estimated
Read moreItalian IT and complex database consultancy Nubilaria is offering it’s cutting edge ACTide EDC web platform free of charge to
Read more